In the 95–600 mg tumor group, depletion of CD8+ cells alone or both CD4+ and CD8+ cells diminished the effect of NK cell therapy, whereas depletion of CD4+ cells alone did not affect OS (Figure 3D). The gene discussed is CD4; the disease is neoplasm.